National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

Blood. 1996 Jun 15;87(12):4990-7.

Authors

B D Cheson¹, J M Bennett, M Grever, N Kay, M J Keating, S O'Brien, K R Rai

Affiliation

¹ National Cancer Institute, Bethesda, MD 20892-7436, USA.

PMID: 8652811

No abstract available

Publication types

Guideline
Practice Guideline

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow / pathology
Chromosome Aberrations
Clinical Trials as Topic / methods
Clinical Trials as Topic / standards
Diagnosis, Differential
Humans
Immunophenotyping
Infections / etiology
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
Leukemia, Lymphocytic, Chronic, B-Cell* / therapy
Lymphocyte Count
National Institutes of Health (U.S.)
Neoplasm Staging
Neutropenia / chemically induced
Neutropenia / complications
Patient Selection
Treatment Outcome
United States